Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Dec 9, 2013
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medgenics, Inc.
| -2.00K |
$6.50 | -$13,000.00 | -44.44% | 2.5K |
Dec 6
| |||||||
Medgenics, Inc.
| 1K |
$4.14 | $4,140.00 | +28.57% | 4.5K |
Jun 3 - Jun 4
| |||||||
Medgenics, Inc.
| 3.5K |
$3.64 | $12,740.00 |
∞
| 3.5K |
Mar 20
| |||||||
Medgenics, Inc.
| -3.01K |
$10.74 | -$32,295.18 | -100.00% |
0
|
Sep 14
| |||||||
Medgenics, Inc.
| 3.01K |
$7.87 | $6.70 |
∞
| 3.01K |
Sep 11
| |||||||
Medgenics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Medgenics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Xoma Ltd /de/
| -10.97K |
$1.41 | -$15,490.94 | -9.76% | 101.46K | +1 |
May 11
| ||||||
Xoma Ltd /de/
| 13.75K |
$1.43 | $19,598.03 | +13.94% | 112.43K | +1 |
Mar 15
| ||||||
Xoma Ltd /de/
| 3.06K |
$2.61 | $8,000.10 | +23.73% | 15.98K | +1 |
Dec 31
| ||||||
Xoma Ltd /de/
| -4.29K |
$2.51 | -$10,777.94 | -4.17% | 98.68K | +1 |
Sep 17
| ||||||
Xoma Ltd /de/
| -4.00K |
$4.75 | -$19,000.00 | -3.74% | 102.97K | +1 |
Jun 30
| ||||||
Xoma Ltd /de/
| 5.74K |
$6.45 | $37,013.69 | +5.66% | 106.97K | +1 |
Mar 15
| ||||||
Xoma Ltd /de/
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 25
| ||||||
Xoma Ltd /de/
| -15.97K |
$7.49 | -$119,607.81 | -13.62% | 101.24K | +1 |
Jan 9
| ||||||
Xoma Ltd /de/
| 23.97K |
$2.56 | $61,420.56 | +25.71% | 117.2K | +1 |
Jan 2
| ||||||
Xoma Ltd /de/
| 1.05K |
$6.64 | $6,997.72 | +8.89% | 12.91K | +1 |
Dec 31
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||